(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report :November 19, 2021 ...https://www.marketscreener.com/quote/stock/ACCELERON-PHARMA-INC-14297719/news/Acceleron-Pharma-Completion-of-Acquisition-or-Disposition-of-Assets-Form-8-K-37102234/?utm_medium=RSS&utm_content=20211122
Acceleron is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of pulmonary and hematologic diseases.